dipyridamole has been researched along with Ischemia in 82 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Extended release dipyridamole (ERD) is widely used in patients after ischaemic stroke; however, the ability of this antithrombotic agent to be stored in different blood cells has never been explored in post-stroke patients." | 9.14 | Distribution of dipyridamole in blood components among post-stroke patients treated with extended release formulation. ( Atar, OD; Booze, C; Eisert, C; Hanley, D; Sabaeva, E; Serebruany, V, 2009) |
| "Headache is reported by about one third of patients using dipyridamole (DP) after stroke or TIA." | 9.11 | Dipyridamole and headache--a pilot study of initial dose titration. ( Husted, S; Lindgren, A; Staaf, G; Ziegler, B, 2004) |
| "32 patients (mean age 65 years, range 51-75 years) were included in this controlled, double blind study to evaluate the effect of dipyridamole in patients with intermittent claudication." | 9.07 | [Double-blind study of the effect of dipyridamole in patients with intermittent claudication]. ( Baumgartner, I; Bollinger, A; Schalch, I, 1992) |
| "A randomized, double-blind, placebo-controlled study was performed to investigate the effect of dipyridamole at a usual oral dose of 150 mg/day on 18 patients with angina pectoris and positive treadmill exercise electrocardiography." | 9.06 | Effect of dipyridamole at the usual oral dose on exercise-induced myocardial ischemia in stable angina pectoris. ( Horie, H; Ishikawa, K; Okada, M; Tsuya, T, 1990) |
| "Dipyridamole anti-platelet therapy has previously been suggested to ameliorate chronic tissue ischemia in healthy animals." | 7.77 | Dipyridamole reverses peripheral ischemia and induces angiogenesis in the Db/Db diabetic mouse hind-limb model by decreasing oxidative stress. ( Bir, SC; Branch, BG; Greber, E; Kevil, CG; Pardue, S; Patel, RP; Pattillo, CB; Shen, X, 2011) |
| "Six patients with advanced arteriosclerosis obliterans in the lower extremities were subjected to an exercise test on a tread mill with and without dipyridamole treatment." | 7.66 | Lack of effect of ischemia and dipyridamole on prostacyclin production in arteriosclerosis obliterans. ( Kärkölä, P; Pokela, R; Viinikka, L; Ylikorkala, O, 1981) |
| " We have found that the beneficial effects of dipyridamole therapy are due to its ability to increase tissue nitric oxide bioavailability that corrects tissue redox imbalance." | 6.46 | Reperfusion of chronic tissue ischemia: nitrite and dipyridamole regulation of innate immune responses. ( Fang, K; Kevil, CG; Pattillo, CB; Terracciano, J, 2010) |
| "1 The effects of propranolol and practolol, at equivalent myocardial beta-adrenoceptor blocking doses, (as assessed by the degree of shift of isoprenaline dose-response curves) were investigated in anaesthetized greyhounds before and after acute coronary artery ligation." | 5.26 | Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction. ( Marshall, RJ; Parratt, JR, 1976) |
| "Extended release dipyridamole (ERD) is widely used in patients after ischaemic stroke; however, the ability of this antithrombotic agent to be stored in different blood cells has never been explored in post-stroke patients." | 5.14 | Distribution of dipyridamole in blood components among post-stroke patients treated with extended release formulation. ( Atar, OD; Booze, C; Eisert, C; Hanley, D; Sabaeva, E; Serebruany, V, 2009) |
| "Headache is reported by about one third of patients using dipyridamole (DP) after stroke or TIA." | 5.11 | Dipyridamole and headache--a pilot study of initial dose titration. ( Husted, S; Lindgren, A; Staaf, G; Ziegler, B, 2004) |
| "32 patients (mean age 65 years, range 51-75 years) were included in this controlled, double blind study to evaluate the effect of dipyridamole in patients with intermittent claudication." | 5.07 | [Double-blind study of the effect of dipyridamole in patients with intermittent claudication]. ( Baumgartner, I; Bollinger, A; Schalch, I, 1992) |
| "A randomized, double-blind, placebo-controlled study was performed to investigate the effect of dipyridamole at a usual oral dose of 150 mg/day on 18 patients with angina pectoris and positive treadmill exercise electrocardiography." | 5.06 | Effect of dipyridamole at the usual oral dose on exercise-induced myocardial ischemia in stable angina pectoris. ( Horie, H; Ishikawa, K; Okada, M; Tsuya, T, 1990) |
| "Dipyridamole anti-platelet therapy has previously been suggested to ameliorate chronic tissue ischemia in healthy animals." | 3.77 | Dipyridamole reverses peripheral ischemia and induces angiogenesis in the Db/Db diabetic mouse hind-limb model by decreasing oxidative stress. ( Bir, SC; Branch, BG; Greber, E; Kevil, CG; Pardue, S; Patel, RP; Pattillo, CB; Shen, X, 2011) |
| "Exercise electrocardiography and pharmacological stress echocardiography (171 dipyridamole, 73 dobutamine) were performed in 244 women (age 60+/-10 years) with chest pain and known coronary artery disease." | 3.71 | The incremental prognostic value of pharmacological stress echo over exercise electrocardiography in women with chest pain of unknown origin. ( Azzarelli, A; Cortigiani, L; Dodi, C; Masini, M; Nannini, E; Olivotto, I, 2001) |
| "Prostacyclin, the stable prostacyclin analogue carbacyclin, the thromboxane synthetase inhibitor UK-38,485, and the phosphodiesterase inhibitor dipyridamole were tested on rabbit epigastric free flaps for their ability to improve flap survival after a period of ischemia." | 3.68 | Prostacyclin and prostanoid modifiers aid ischemic skin flap survival. ( Angus, JA; Coe, SA; Kawabata, H; Knight, KR; O'Brien, BM; Sakai, K, 1991) |
| " Twenty-nine studies were performed at control, 13 during ischemia, eight after reperfusion, 13 during dipyridamole-induced hyperemia, and two during alteration of cardiac workload." | 3.68 | Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. ( Armbrecht, JJ; Buxton, DB; Schelbert, HR, 1990) |
| "Six patients with advanced arteriosclerosis obliterans in the lower extremities were subjected to an exercise test on a tread mill with and without dipyridamole treatment." | 3.66 | Lack of effect of ischemia and dipyridamole on prostacyclin production in arteriosclerosis obliterans. ( Kärkölä, P; Pokela, R; Viinikka, L; Ylikorkala, O, 1981) |
| "Thirty-five patients with gangrene or pregangrene of the feed associated with palpable peripheral pulses have been treated with the platelet suppressive drugs aspirin and dipyridamole." | 3.66 | Gangrene of the toes with palpable peripheral pulses. ( Chatterjee, DK; Greaney, M; Morris-Jones, W; Preston, FE, 1981) |
| " We have found that the beneficial effects of dipyridamole therapy are due to its ability to increase tissue nitric oxide bioavailability that corrects tissue redox imbalance." | 2.46 | Reperfusion of chronic tissue ischemia: nitrite and dipyridamole regulation of innate immune responses. ( Fang, K; Kevil, CG; Pattillo, CB; Terracciano, J, 2010) |
| "Dipyridamole was first introduced as an antianginal, coronary vasodilator agent." | 2.38 | Dipyridamole-echocardiography test: historical background and physiologic basis. ( Picano, E, 1989) |
| "Dipyridamole treatment quickly restored ischaemic hindlimb blood flow, increased vascular density and cell proliferation, and enhanced collateral artery perfusion compared with control treatments." | 1.36 | Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway. ( Branch, B; Hood, J; Illum, S; Kevil, CG; Pardue, S; Patel, RP; Pattillo, CB; Teng, X; Thoma, S; Venkatesh, PK, 2010) |
| "We report a 1-month-old infant with Kawasaki disease and peripheral gangrene." | 1.33 | Infantile Kawasaki disease and peripheral gangrene. ( Durall, AL; Mullett, CJ; Phillips, JR; Weisse, ME, 2006) |
| "Adverse cardiac events were defined as congestive heart failure (CHF), myocardial infarction (MI), unstable angina (USA), and ventricular arrhythmias." | 1.31 | An abnormal dipyridamole thallium/sestamibi fails to predict long-term cardiac events in vascular surgery patients. ( de Virgilio, C; Donayre, C; Elbassir, M; Ephraim, L; Toosie, K; Wall, DB; White, R, 2001) |
| "The diazoxide-mediated increase in the forearm blood flow ratio (infused/control arm) was significantly less pronounced after glibenclamide than after acarbose (290 +/- 58% and 561 +/- 101% respectively; P<0." | 1.31 | Vascular K(ATP) channel blockade by glibenclamide, but not by acarbose, in patients with Type II diabetes. ( Abbink, EJ; Lutterman, JA; Pickkers, P; Russel, FG; Smits, P; Tack, CJ; van Rosendaal, AJ, 2002) |
| "Indications for surgery included vertebrobasilar insufficiency (22." | 1.30 | Carotid-subclavian bypass for subclavian artery revascularization: long-term follow-up and effect of antiplatelet therapy. ( Dresler, C; Haverich, A; Wahlers, T; Wittwer, T, 1998) |
| "Method of complex surgical treatment of inguinal hernia in children, basing on the early conduction of surgical correction of pathology, application of microsurgical technique of the operation conduction, using of pharmacologic defense of hematotesticular barrier and medicinal therapy of the man sexual gland ischemia, was elaborated and substantiated." | 1.30 | [Substantiation of complex surgical treatment of inguinal hernia in children based on pathogenetic criteria]. ( Horbatiuk, OM, 1998) |
| "Dipyridamole pretreatment did not affect the right kidney, but it intensified the reductions in left kidney CPAH, CIn, and FF." | 1.27 | The effect of dipyridamole on the initiation phase of postischemic acute renal failure in rats. ( Bidani, AK; Churchill, PC; Lin, JJ, 1987) |
| "1 The effects of propranolol and practolol, at equivalent myocardial beta-adrenoceptor blocking doses, (as assessed by the degree of shift of isoprenaline dose-response curves) were investigated in anaesthetized greyhounds before and after acute coronary artery ligation." | 1.26 | Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction. ( Marshall, RJ; Parratt, JR, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 41 (50.00) | 18.7374 |
| 1990's | 16 (19.51) | 18.2507 |
| 2000's | 14 (17.07) | 29.6817 |
| 2010's | 11 (13.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bath, PM | 1 |
| Woodhouse, LJ | 1 |
| Appleton, JP | 1 |
| Beridze, M | 1 |
| Christensen, H | 1 |
| Dineen, RA | 1 |
| Duley, L | 1 |
| England, TJ | 1 |
| Flaherty, K | 1 |
| Havard, D | 1 |
| Heptinstall, S | 1 |
| James, M | 1 |
| Krishnan, K | 1 |
| Markus, HS | 1 |
| Montgomery, AA | 1 |
| Pocock, SJ | 1 |
| Randall, M | 1 |
| Ranta, A | 1 |
| Robinson, TG | 1 |
| Scutt, P | 1 |
| Venables, GS | 1 |
| Sprigg, N | 1 |
| Carboni, GP | 1 |
| Sedati, P | 1 |
| De Marco, E | 1 |
| Azarbal, A | 1 |
| Clavijo, L | 1 |
| Gaglia, MA | 1 |
| Serebruany, V | 1 |
| Sabaeva, E | 1 |
| Booze, C | 1 |
| Atar, OD | 1 |
| Eisert, C | 1 |
| Hanley, D | 1 |
| Venkatesh, PK | 1 |
| Pattillo, CB | 3 |
| Branch, B | 1 |
| Hood, J | 1 |
| Thoma, S | 1 |
| Illum, S | 1 |
| Pardue, S | 2 |
| Teng, X | 1 |
| Patel, RP | 2 |
| Kevil, CG | 3 |
| Zakavi, SR | 1 |
| Taherpour, M | 1 |
| Saleh, F | 1 |
| Sadeghi, R | 1 |
| Kakhki, VR | 1 |
| Fang, K | 1 |
| Terracciano, J | 1 |
| Bir, SC | 1 |
| Branch, BG | 1 |
| Greber, E | 1 |
| Shen, X | 1 |
| Johnson, NP | 1 |
| Lance Gould, K | 1 |
| Aw, D | 1 |
| Sharma, JC | 1 |
| Grenz, A | 1 |
| Bauerle, JD | 1 |
| Dalton, JH | 1 |
| Ridyard, D | 1 |
| Badulak, A | 1 |
| Tak, E | 1 |
| McNamee, EN | 1 |
| Clambey, E | 1 |
| Moldovan, R | 1 |
| Reyes, G | 1 |
| Klawitter, J | 1 |
| Ambler, K | 1 |
| Magee, K | 1 |
| Christians, U | 1 |
| Brodsky, KS | 1 |
| Ravid, K | 1 |
| Choi, DS | 1 |
| Wen, J | 1 |
| Lukashev, D | 1 |
| Blackburn, MR | 1 |
| Osswald, H | 1 |
| Coe, IR | 1 |
| Nürnberg, B | 1 |
| Haase, VH | 1 |
| Xia, Y | 1 |
| Sitkovsky, M | 1 |
| Eltzschig, HK | 1 |
| Ferreira-González, L | 1 |
| Trigás-Ferrín, M | 1 |
| Rubin, EP | 1 |
| Sesma, P | 1 |
| CASELLAS BERNAT, A | 1 |
| TRILLA SANCHEZ, E | 1 |
| DE-VOS BERRUETA, M | 1 |
| GAUSI GENE, C | 1 |
| HOELSCHER, B | 1 |
| Rao, U | 1 |
| Weston, C | 1 |
| Lindgren, A | 1 |
| Husted, S | 1 |
| Staaf, G | 1 |
| Ziegler, B | 1 |
| Jones, L | 1 |
| Griffin, S | 1 |
| Palmer, S | 1 |
| Main, C | 1 |
| Orton, V | 1 |
| Sculpher, M | 1 |
| Sudlow, C | 1 |
| Henderson, R | 1 |
| Hawkins, N | 1 |
| Riemsma, R | 1 |
| Heston, TF | 1 |
| Sigg, DM | 1 |
| Durall, AL | 1 |
| Phillips, JR | 1 |
| Weisse, ME | 1 |
| Mullett, CJ | 1 |
| Meijer, P | 1 |
| Wouters, CW | 1 |
| van den Broek, PH | 1 |
| Scheffer, GJ | 1 |
| Riksen, NP | 1 |
| Smits, P | 2 |
| Rongen, GA | 1 |
| Moir, TW | 1 |
| DeBra, DW | 1 |
| Garvin, PJ | 2 |
| Carney, K | 2 |
| Jellinek, M | 2 |
| Niehoff, M | 1 |
| Castaneda, M | 1 |
| Codd, JE | 2 |
| Liguori, J | 1 |
| Werres, R | 1 |
| Rothfeld, D | 1 |
| Fradà, G | 1 |
| Okiye, S | 1 |
| Viinikka, L | 1 |
| Kärkölä, P | 1 |
| Pokela, R | 1 |
| Ylikorkala, O | 1 |
| Tavazzi, L | 1 |
| Previtali, M | 1 |
| Salerno, JA | 1 |
| Chimienti, M | 1 |
| Ray, M | 1 |
| Medici, A | 1 |
| Specchia, G | 1 |
| Bobba, P | 1 |
| Broomé, A | 1 |
| Davidsson, T | 1 |
| Eklöf, B | 1 |
| Hansson, L | 1 |
| Morris-Jones, W | 1 |
| Preston, FE | 1 |
| Greaney, M | 1 |
| Chatterjee, DK | 1 |
| DelBeccaro, EJ | 1 |
| Robson, MC | 1 |
| Heggers, JP | 1 |
| Swaminathan, R | 1 |
| Bajnok, L | 1 |
| Kozlovszky, B | 1 |
| Varga, J | 1 |
| Antalffy, J | 1 |
| Olvasztó, S | 1 |
| Fülöp, T | 1 |
| Connor, SJ | 1 |
| Nukada, H | 1 |
| Sarin, S | 1 |
| Shami, SK | 1 |
| Cheatle, TR | 1 |
| Bearn, P | 1 |
| Scurr, JH | 1 |
| Coleridge Smith, PD | 1 |
| Kresowik, TF | 1 |
| Hoballah, JJ | 1 |
| Sharp, WJ | 1 |
| Corson, JD | 1 |
| Wittwer, T | 1 |
| Wahlers, T | 1 |
| Dresler, C | 1 |
| Haverich, A | 1 |
| Horbatiuk, OM | 1 |
| Cohen, MC | 1 |
| Curran, PJ | 1 |
| L'Italien, GJ | 1 |
| Mittleman, MA | 1 |
| Zarich, SW | 1 |
| Rosen, SD | 1 |
| Lorenzoni, R | 1 |
| Kaski, JC | 1 |
| Foale, RA | 1 |
| Camici, PG | 1 |
| Holdright, DR | 1 |
| Dodi, C | 1 |
| Cortigiani, L | 1 |
| Masini, M | 1 |
| Olivotto, I | 1 |
| Azzarelli, A | 1 |
| Nannini, E | 1 |
| Bergmann, SR | 1 |
| de Virgilio, C | 1 |
| Wall, DB | 1 |
| Ephraim, L | 1 |
| Toosie, K | 1 |
| Donayre, C | 1 |
| White, R | 1 |
| Elbassir, M | 1 |
| Wolf, YG | 1 |
| Landersberg, G | 1 |
| Mosseri, M | 1 |
| Schechter, D | 1 |
| Anner, H | 1 |
| Weissman, C | 1 |
| Berlatzky, Y | 1 |
| Karimov, ZZ | 1 |
| Bakhritdinov, FSh | 1 |
| Trynkin, AV | 1 |
| Abbink, EJ | 1 |
| Pickkers, P | 1 |
| van Rosendaal, AJ | 1 |
| Lutterman, JA | 1 |
| Tack, CJ | 1 |
| Russel, FG | 1 |
| Takeda, K | 1 |
| Nakagawa, Y | 1 |
| Katono, Y | 1 |
| Imai, S | 1 |
| Callis, M | 1 |
| Weiss, HJ | 2 |
| Guiraud, B | 1 |
| David, J | 1 |
| Géraud, G | 1 |
| Biermé, R | 1 |
| Rascol, A | 1 |
| Porter, JM | 1 |
| Goodnight, SH | 1 |
| Gotshall, RA | 1 |
| Harker, LA | 1 |
| Marshall, RJ | 2 |
| Parratt, JR | 2 |
| Baumgartner, I | 1 |
| Schalch, I | 1 |
| Bollinger, A | 1 |
| Gruel, Y | 1 |
| Lermusiaux, P | 1 |
| Lang, M | 1 |
| Darnige, L | 1 |
| Rupin, A | 1 |
| Delahousse, B | 1 |
| Guilmot, JL | 1 |
| Leroy, J | 1 |
| Hugtenburg, JG | 1 |
| Mathy, MJ | 1 |
| de Haan, N | 1 |
| Beckeringh, JJ | 1 |
| van Zwieten, PA | 1 |
| McCollum, C | 1 |
| Kenchington, G | 1 |
| Alexander, C | 1 |
| Franks, PJ | 1 |
| Greenhalgh, RM | 1 |
| Knight, KR | 1 |
| Kawabata, H | 1 |
| Coe, SA | 1 |
| Angus, JA | 1 |
| O'Brien, BM | 2 |
| Sakai, K | 1 |
| Armbrecht, JJ | 1 |
| Buxton, DB | 1 |
| Schelbert, HR | 1 |
| Tsuya, T | 1 |
| Okada, M | 1 |
| Horie, H | 1 |
| Ishikawa, K | 1 |
| Picano, E | 1 |
| Berne, RM | 1 |
| Belardinelli, L | 1 |
| Lin, JJ | 1 |
| Churchill, PC | 1 |
| Bidani, AK | 1 |
| Lewen, MK | 1 |
| Labovitz, AJ | 1 |
| Kern, MJ | 1 |
| Chaitman, BR | 1 |
| Sax, FL | 1 |
| Cannon, RO | 1 |
| Hanson, C | 1 |
| Epstein, SE | 1 |
| Wilding, RP | 1 |
| Flute, PT | 1 |
| Hahn, N | 1 |
| Felix, R | 1 |
| Hayhurst, JW | 1 |
| Ishida, H | 1 |
| Baxter, TJ | 1 |
| Calman, KC | 1 |
| Cibulski, AA | 1 |
| Lehan, PH | 1 |
| Timmis, HH | 1 |
| Becker, RM | 1 |
| Shizgal, HM | 1 |
| Dobell, AR | 1 |
| Ledingham, IM | 1 |
| Howenstine, JA | 1 |
| Slaton, P | 1 |
| Spitalny, A | 1 |
| Lee, J | 1 |
| Schoen, HR | 1 |
| Voss, R | 1 |
| Ruile, K | 1 |
| Wildberger, JE | 1 |
| Gerlach, E | 1 |
| Deuticke, B | 1 |
| Seeman, T | 1 |
| Kaltenbach, M | 1 |
| Kübler, W | 1 |
| Spieckermann, PG | 1 |
| Bretschneider, HJ | 1 |
| Winbury, MM | 1 |
| Losada, M | 1 |
| Kissil, D | 1 |
| Howe, BB | 1 |
| Pensinger, RR | 1 |
| Kontos, HA | 1 |
| Goldin, D | 1 |
| Richardson, DW | 1 |
| Patterson, JL | 1 |
| Schlosser, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Is Augmentation of PORH by Rosuvastatin Adenosine-receptor Mediated?[NCT00851175] | Phase 4 | 8 participants (Anticipated) | Interventional | 2009-03-31 | Completed | ||
| The Impact of Cardiac Rehabilitation on Angina Frequency, Psychological Morbidity and Quality of Life in Women With Syndrome X[NCT00123617] | Phase 2 | 64 participants (Actual) | Interventional | 2003-01-31 | Completed | ||
| CORonary MICrovascular Angina (CorMicA): a Randomised, Controlled, Pilot Trial[NCT03193294] | 151 participants (Actual) | Interventional | 2016-11-07 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for dipyridamole and Ischemia
| Article | Year |
|---|---|
Antiplatelet therapy for peripheral arterial disease and critical limb ischemia: guidelines abound, but where are the data?
Topics: Aspirin; Cilostazol; Dipyridamole; Endovascular Procedures; Extremities; Humans; Ischemia; Periphera | 2015 |
Reperfusion of chronic tissue ischemia: nitrite and dipyridamole regulation of innate immune responses.
Topics: Animals; Dipyridamole; Down-Regulation; Humans; Immunity, Innate; Inflammation; Ischemia; Neovascula | 2010 |
Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice?
Topics: Aspirin; Clopidogrel; Dipyridamole; Humans; Ischemia; Ischemic Attack, Transient; Platelet Aggregati | 2012 |
Antiplatelet agents in atherothrombotic diseases.
Topics: Arteriosclerosis; Aspirin; Clopidogrel; Dipyridamole; Humans; Ischemia; Platelet Aggregation Inhibit | 2004 |
Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.
Topics: Aspirin; Clopidogrel; Cost-Benefit Analysis; Delayed-Action Preparations; Diarrhea; Dipyridamole; Dr | 2004 |
When do vascular surgeons prescribe antiplatelet therapy? Current attitudes.
Topics: Angioplasty, Balloon; Arteriosclerosis; Aspirin; Dipyridamole; Graft Occlusion, Vascular; Humans; Is | 1993 |
Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Brain; Clofibrate; Dextrans; Dipyridamole; Humans; Ischemi | 1976 |
Dipyridamole-echocardiography test: historical background and physiologic basis.
Topics: Coronary Disease; Dipyridamole; Echocardiography; Exercise Test; Humans; Ischemia | 1989 |
10 trials available for dipyridamole and Ischemia
| Article | Year |
|---|---|
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
Topics: Acute Disease; Aged; Aspirin; Brain Ischemia; Clopidogrel; Denmark; Dipyridamole; Drug Therapy, Comb | 2018 |
Distribution of dipyridamole in blood components among post-stroke patients treated with extended release formulation.
Topics: Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Platelets; Delayed-Action Preparations; | 2009 |
Dipyridamole and headache--a pilot study of initial dose titration.
Topics: Aged; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Headache; Humans; | 2004 |
Dipyridamole enhances ischaemia-induced reactive hyperaemia by increased adenosine receptor stimulation.
Topics: Adult; Caffeine; Central Nervous System Stimulants; Dipyridamole; Female; Forearm; Humans; Hyperemia | 2008 |
Platelet inhibition with ASA/dipyridamole after percutaneous balloon angioplasty in patients with symptomatic lower limb arterial disease. A prospective double-blind trial. Study group on pharmacological treatment after PTA.
Topics: Aged; Angiography; Angioplasty, Balloon; Aspirin; Dipyridamole; Double-Blind Method; Drug Combinatio | 1994 |
Effect of alpha1-adrenoceptor blockade on coronary vasodilator reserve in cardiac syndrome X.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Angina Pectoris; Dipyridamole; Double-Blind Method; Doxaz | 1999 |
Proceedings: Prevention of ischemic cerebro vascular accident: a long term clinical trial with vasodilator and antiaggregating drugs.
Topics: Aspirin; Brain; Clinical Trials as Topic; Dihydroergotoxine; Dipyridamole; Ergoloid Mesylates; Human | 1975 |
[Double-blind study of the effect of dipyridamole in patients with intermittent claudication].
Topics: Aged; Dipyridamole; Double-Blind Method; Exercise Test; Female; Humans; Intermittent Claudication; I | 1992 |
PTFE or HUV for femoro-popliteal bypass: a multi-centre trial.
Topics: Arterial Occlusive Diseases; Aspirin; Bioprosthesis; Blood Vessel Prosthesis; Combined Modality Ther | 1991 |
Effect of dipyridamole at the usual oral dose on exercise-induced myocardial ischemia in stable angina pectoris.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Coronary Circulation; Dipyridamole; Double-Blind | 1990 |
64 other studies available for dipyridamole and Ischemia
| Article | Year |
|---|---|
Anomalous left main coronary artery origin, silent ischaemia, risk of sudden death: a triad detected by combining coronary CT and dipyridamole SPECT.
Topics: Aged; Coronary Vessel Anomalies; Death, Sudden, Cardiac; Dipyridamole; Humans; Ischemia; Male; Multi | 2013 |
Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway.
Topics: Animals; Cell Division; Chronic Disease; Cyclic AMP-Dependent Protein Kinases; Dipyridamole; Dose-Re | 2010 |
Electrocardiographic changes after dipyridamole infusion in patients undergoing myocardial perfusion imaging.
Topics: Adult; Aged; Aged, 80 and over; Dipyridamole; Electrocardiography; Female; Humans; Infusion Pumps; I | 2010 |
Dipyridamole reverses peripheral ischemia and induces angiogenesis in the Db/Db diabetic mouse hind-limb model by decreasing oxidative stress.
Topics: Animals; Diabetes Mellitus, Experimental; Dipyridamole; Disease Models, Animal; Hindlimb; Hyperchole | 2011 |
Dipyridamole reversal using theophylline during aminophylline shortage.
Topics: Aminophylline; Dipyridamole; Drug Substitution; Humans; Ischemia; Theophylline; Therapeutic Equivale | 2011 |
Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice.
Topics: Acute Kidney Injury; Adenosine; Animals; Cell Line; Chimerism; Dipyridamole; Equilibrative Nucleosid | 2012 |
Pituitary apoplexy after myocardial perfusion scintigraphy.
Topics: Adenoma; Aged; Angina, Unstable; Anticoagulants; Cardiac Pacing, Artificial; Dipyridamole; Female; H | 2012 |
[Clinico-experipyrimido (5,4-d) pyrimidine].
Topics: Angina Pectoris; Dipyridamole; Heart Diseases; Humans; Intracranial Embolism; Intracranial Embolism | 1963 |
[STUDIES ON THE PROLONGATION AND SURVIVAL TIME OF ISOLATED RABBIT HEART AFTER PRELIMINARY TREATMENT WITH 2,6-BIS-(DIETHANOLAMINO)-4,8-DIPIPERIDNOPYRIMIDO(5,4-D)PYRIMIDINE].
Topics: Adenosine Triphosphate; Animals; Dipyridamole; Heart; Heart Arrest; Ischemia; Pharmacology; Pyrimidi | 1964 |
Quantifying transient ischemic dilation using gated SPECT.
Topics: Aged; Dipyridamole; Female; Gated Blood-Pool Imaging; Heart Ventricles; Humans; Image Processing, Co | 2005 |
Infantile Kawasaki disease and peripheral gangrene.
Topics: Abciximab; Amputation, Surgical; Anti-Bacterial Agents; Antibodies, Monoclonal; Anticoagulants; Anti | 2006 |
Effect of left ventricular hypertension, ischemia and vasoactive drugs on the myocardial distribution of coronary flow.
Topics: Animals; Coronary Vessels; Dipyridamole; Electrocardiography; Heart; Heart Ventricles; Hypertension; | 1967 |
The effects of ATP-MgCl2 and dipyridamole in cold-storage preservation.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Cold Temperature; Dipyridamole; Dogs; Female; | 1983 |
Percutaneous transluminal coronary angioplasty at a community hospital--initial experience.
Topics: Adult; Angioplasty, Balloon; Aspirin; Coronary Vessels; Dipyridamole; Female; Hospitals, Community; | 1982 |
[Ischemic syndrome of the lower extremities from immersion in hot water].
Topics: Aged; Dipyridamole; Hot Temperature; Humans; Ischemia; Male; Platelet Aggregation; Toes | 1984 |
The effect of ATP-MgCl2 and dipyridamole pretreatment in renal preservation.
Topics: Adenosine Triphosphate; Animals; Dipyridamole; Dogs; Female; Graft Survival; Ischemia; Kidney; Kidne | 1982 |
Lack of effect of ischemia and dipyridamole on prostacyclin production in arteriosclerosis obliterans.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Arteriosclerosis Obliterans; Dipyridamole; Epoprostenol; Humans; | 1981 |
Dipyridamole test in angina pectoris: diagnostic value and pathophysiological implications.
Topics: Adult; Aged; Angina Pectoris; Coronary Angiography; Coronary Circulation; Coronary Disease; Coronary | 1982 |
Effect of platelet aggregation inhibitors on the rate of thrombectomy following arterial reconstructions with Gore-Tex prostheses: a retrospective study.
Topics: Aspirin; Blood Vessel Prosthesis; Dipyridamole; Humans; Ischemia; Leg; Platelet Aggregation; Postope | 1982 |
Gangrene of the toes with palpable peripheral pulses.
Topics: Aged; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Gangrene; Humans; Ischemia; Male; Mi | 1981 |
The use of specific thromboxane inhibitors to preserve the dermal microcirculation after burning.
Topics: Animals; Burns; Dipyridamole; Female; Guinea Pigs; Heterocyclic Compounds; Imidazoles; Ischemia; Met | 1980 |
Technetium-99m sestamibi scintigraphy for the assessment of lower extremity ischaemia in peripheral arterial disease.
Topics: Dipyridamole; Female; Heart; Humans; Ischemia; Leg; Male; Middle Aged; Peripheral Vascular Diseases; | 1994 |
Vasodilating effect of dipyridamole on rat endoneurial vessels: morphometric study.
Topics: Animals; Dipyridamole; Ischemia; Male; Peripheral Nerves; Peripheral Nervous System Diseases; Random | 1993 |
Cardiac screening tests prior to lower extremity revascularization: routine versus selective application.
Topics: Coronary Disease; Dipyridamole; Heart Function Tests; Humans; Inguinal Canal; Ischemia; Leg; Periphe | 1997 |
Carotid-subclavian bypass for subclavian artery revascularization: long-term follow-up and effect of antiplatelet therapy.
Topics: Adult; Aged; Angiography; Anticoagulants; Arm; Arterial Occlusive Diseases; Aspirin; Blood Vessel Pr | 1998 |
[Substantiation of complex surgical treatment of inguinal hernia in children based on pathogenetic criteria].
Topics: Age Factors; Antioxidants; Ascorbic Acid; Aspirin; Blood-Testis Barrier; Child; Dipyridamole; Hernia | 1998 |
Long-term prognostic value of preoperative dipyridamole thallium imaging and clinical indexes in patients with diabetes mellitus undergoing peripheral vascular surgery.
Topics: Aged; Diabetic Angiopathies; Dipyridamole; Female; Follow-Up Studies; Heart Diseases; Humans; Ischem | 1999 |
The role of pharmacological stress echo for evaluating chest pain in women.
Topics: Chest Pain; Coronary Disease; Dipyridamole; Dobutamine; Echocardiography; Electrocardiography; Exerc | 2001 |
The incremental prognostic value of pharmacological stress echo over exercise electrocardiography in women with chest pain of unknown origin.
Topics: Aged; Chest Pain; Dipyridamole; Dobutamine; Echocardiography; Electrocardiography; Exercise Test; Fe | 2001 |
Aggrenox and stress testing.
Topics: Adenosine; Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Humans; | 2001 |
An abnormal dipyridamole thallium/sestamibi fails to predict long-term cardiac events in vascular surgery patients.
Topics: Aged; Aortic Diseases; Cause of Death; Dipyridamole; Female; Follow-Up Studies; Heart Failure; Human | 2001 |
Preoperative dipyridamole-thallium scanning, selective coronary revascularization and long-term survival in patients with critical lower limb ischemia.
Topics: Aged; Angioplasty, Balloon, Coronary; Chronic Disease; Coronary Artery Bypass; Coronary Disease; Dip | 2001 |
[Prolonged intra-arterial therapy in surgical treatment of patients with critical lower limb ischemia].
Topics: Actihaemyl; Adult; Aged; Aged, 80 and over; Amputation, Surgical; Anticoagulants; Critical Care; Dip | 2001 |
Vascular K(ATP) channel blockade by glibenclamide, but not by acarbose, in patients with Type II diabetes.
Topics: Acarbose; Acetylcholine; Cross-Over Studies; Diabetes Mellitus, Type 2; Diazoxide; Dipyridamole; Dou | 2002 |
Effects of coronary vasodilators on large and small coronary arteries of dogs.
Topics: Adenosine; Animals; Arteries; Coronary Circulation; Coronary Vessels; Dipyridamole; Dogs; Erythritol | 1977 |
[Ischemic lesions in polycythaemia vera (author's transl)].
Topics: Aspirin; Dipyridamole; Female; Foot; Humans; Ischemia; Male; Middle Aged; Pain; Polycythemia Vera; S | 1977 |
The role of the platelet in coagulation and clinical thrombotic events.
Topics: Blood Coagulation; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Coronary Disease; Dipy | 1977 |
Using antithrombotic therapy in ischemic cerebrovascular disease.
Topics: Aspirin; Brain; Cerebrovascular Disorders; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Intra | 1977 |
Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction.
Topics: Animals; Body Temperature; Coronary Circulation; Coronary Vessels; Dipyridamole; Dogs; Female; Hemod | 1976 |
Usefulness of antiplatelet drugs in the management of heparin-associated thrombocytopenia and thrombosis.
Topics: Aged; Aorta, Abdominal; Aspirin; Dipyridamole; Female; Femoral Vein; Heparin; Humans; Iliac Artery; | 1991 |
The influence of calcium antagonists on the adenine nucleotide metabolism in the guinea-pig working heart during ischaemia and reperfusion.
Topics: Adenine Nucleotides; Animals; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Dipyri | 1991 |
Prostacyclin and prostanoid modifiers aid ischemic skin flap survival.
Topics: Animals; Dipyridamole; Epoprostenol; Graft Survival; Imidazoles; Ischemia; Prostaglandins, Synthetic | 1991 |
Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium.
Topics: Acetates; Animals; Carbon Dioxide; Carbon Radioisotopes; Coronary Circulation; Dipyridamole; Dogs; H | 1990 |
Effects of hypoxia and ischaemia on coronary vascular resistance, A-V node conduction and S-A node excitation.
Topics: Adenine Nucleotides; Adenosine; Aminophylline; Atrioventricular Node; Coronary Circulation; Coronary | 1985 |
The effect of dipyridamole on the initiation phase of postischemic acute renal failure in rats.
Topics: Acute Kidney Injury; Animals; Blood Pressure; Dipyridamole; Glomerular Filtration Rate; Ischemia; Ki | 1987 |
Prolonged myocardial ischemia after intravenous dipyridamole thallium imaging.
Topics: Cardiomyopathies; Coronary Disease; Dipyridamole; Echocardiography; Electrocardiography; Female; Hum | 1987 |
Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalized disorder of vascular function?
Topics: Adult; Angina Pectoris; Coronary Circulation; Dipyridamole; Female; Forearm; Humans; Ischemia; Male; | 1987 |
Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalized disorder of vascular function?
Topics: Adult; Angina Pectoris; Coronary Circulation; Dipyridamole; Female; Forearm; Humans; Ischemia; Male; | 1987 |
Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalized disorder of vascular function?
Topics: Adult; Angina Pectoris; Coronary Circulation; Dipyridamole; Female; Forearm; Humans; Ischemia; Male; | 1987 |
Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalized disorder of vascular function?
Topics: Adult; Angina Pectoris; Coronary Circulation; Dipyridamole; Female; Forearm; Humans; Ischemia; Male; | 1987 |
Letter: Dipyridamole in peripheral upper-limb ischaemia.
Topics: Administration, Oral; Aged; Arm; Arterial Occlusive Diseases; Dipyridamole; Female; Humans; Ischemia | 1974 |
[Proceedings: Microcirculation and ventricular-wall function in the normal and partially ischemia-damaged myocardium under pharmacologic influence in animal experiment].
Topics: Adrenergic beta-Antagonists; Animals; Coronary Vessels; Digoxin; Dipyridamole; Dogs; Heart; Ischemia | 1974 |
Experimental digital replantation after prolonged cooling.
Topics: Animals; Arteries; Aspirin; Autopsy; Cold Temperature; Dipyridamole; Fingers; Graft Rejection; Haplo | 1974 |
The prediction of organ viability. II. Testing an hypothesis.
Topics: Adenine Nucleotides; Animals; Dipyridamole; Insulin; Ischemia; Kidney; Models, Biological; Organ Pre | 1974 |
Retrograde flow technique vs. krypton-85 clearance technique for estimation of myocardial collaterals.
Topics: Animals; Blood Pressure; Collateral Circulation; Coronary Circulation; Coronary Disease; Coronary Ve | 1972 |
Distribution of coronary blood flow during cardiopulmonary bypass in pigs.
Topics: Animals; Chromium Isotopes; Coronary Circulation; Dipyridamole; Extracorporeal Circulation; Heart Ve | 1973 |
Drug-induced changes in blood flow in normal and ischaemic regions of the canine myocardium.
Topics: Amino Alcohols; Animals; Blood Pressure; Coronary Circulation; Coronary Vessels; Dipyridamole; Dogs; | 1973 |
Inhibition of platelet-induced thrombus formation.
Topics: Adenosine; Adenosine Diphosphate; Aspirin; Blood Platelets; Brain Diseases; Dipyridamole; Epinephrin | 1974 |
Flank pain and hematuria in a young man with renal artery arteriosclerosis: remission of symptoms during administration of dipyridamole.
Topics: Adult; Angiography; Arteriosclerosis; Dipyridamole; Hematuria; Hemorrhage; Humans; Ischemia; Kidney; | 1974 |
[Animal experimental metabolic studies of the kdneys and their significance for transplantation].
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Dipyridamole; Dogs; Injections, Intravenous; I | 1967 |
[Comparative studies on the formation of adenosine in the myocardium of different animal species in oxygen deficiency].
Topics: Adenine Nucleotides; Aminohydrolases; Animals; Cats; Dipyridamole; Dogs; Guinea Pigs; Haplorhini; He | 1966 |
Pharmacological, rheological and surgical attempts to improve myocardial blood flow during coronary occlusion in dogs.
Topics: Animals; Blood Viscosity; Collateral Circulation; Coronary Disease; Coronary Vessels; Dipyridamole; | 1969 |
[Drug therapy of angina pectoris. Evaluation of various drugs by means of work tests].
Topics: Angina Pectoris; Angiography; Anti-Arrhythmia Agents; Coumarins; Dipyridamole; Electrocardiography; | 1970 |
Influence of dipyridamol (Persantin) on myocardial adenosine metabolism.
Topics: Adenine Nucleotides; Adenosine; Animals; Biological Transport; Cell Membrane Permeability; Coronary | 1970 |
Pentaerythritoltetranitrate and dipyridamole on cardiac nutritive flow and blood content.
Topics: Animals; Autoradiography; Blood Flow Velocity; Collateral Circulation; Coronary Vessels; Dipyridamol | 1971 |
Effect of dipyridamole on vasodilator responses to ischemia, hypoxia, ATP, and AMP.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Blood Pressure; Blood Vessels; Dipyridamole; D | 1968 |
[Immediate postischemic sufficiency of the warm-blooded heart and its pharmacologic control].
Topics: Animals; Blood Pressure Determination; Cardiac Surgical Procedures; Dipyridamole; Dogs; Heart Failur | 1965 |